Enovis Corporation Quick Ratio 2010-2024 | ENOV
Historical quick ratio values for Enovis Corporation (ENOV) over the last 10 years.
| Enovis Corporation Quick Ratio Historical Data |
| Date |
Current Assets - Inventory |
Current Liabilities |
Quick Ratio |
| 2024-09-30 |
$0.59B |
$0.53B |
1.12 |
| 2024-06-30 |
$0.56B |
$0.52B |
1.08 |
| 2024-03-31 |
$0.57B |
$0.55B |
1.03 |
| 2023-12-31 |
$0.43B |
$0.37B |
1.16 |
| 2023-09-30 |
$0.38B |
$0.36B |
1.08 |
| 2023-06-30 |
$0.43B |
$0.35B |
1.23 |
| 2023-03-31 |
$0.39B |
$0.35B |
1.13 |
| 2022-12-31 |
$0.37B |
$0.57B |
0.65 |
| 2022-09-30 |
$0.59B |
$0.85B |
0.69 |
| 2022-06-30 |
$0.68B |
$0.81B |
0.83 |
| 2022-03-31 |
$1.50B |
$1.45B |
1.03 |
| 2021-12-31 |
$1.95B |
$1.02B |
1.90 |
| 2021-09-30 |
$0.95B |
$0.98B |
0.97 |
| 2021-06-30 |
$0.82B |
$0.90B |
0.91 |
| 2021-03-31 |
$1.47B |
$1.56B |
0.94 |
| 2020-12-31 |
$0.80B |
$0.81B |
0.98 |
| 2020-09-30 |
$0.75B |
$0.79B |
0.96 |
| 2020-06-30 |
$0.67B |
$0.76B |
0.89 |
| 2020-03-31 |
$1.02B |
$0.82B |
1.25 |
| 2019-12-31 |
$0.83B |
$0.86B |
0.97 |
| 2019-09-30 |
$2.92B |
$1.51B |
1.94 |
| 2019-06-30 |
$3.04B |
$1.60B |
1.90 |
| 2019-03-31 |
$1.67B |
$1.57B |
1.06 |
| 2018-12-31 |
$1.60B |
$1.20B |
1.33 |
| 2018-09-30 |
$1.47B |
$1.07B |
1.37 |
| 2018-06-30 |
$1.46B |
$1.08B |
1.36 |
| 2018-03-31 |
$1.66B |
$1.10B |
1.52 |
| 2017-12-31 |
$1.64B |
$1.10B |
1.50 |
| 2017-09-30 |
$1.90B |
$1.29B |
1.48 |
| 2017-06-30 |
$1.50B |
$1.15B |
1.31 |
| 2017-03-31 |
$1.35B |
$1.08B |
1.25 |
| 2016-12-31 |
$1.37B |
$1.06B |
1.30 |
| 2016-09-30 |
$1.38B |
$1.08B |
1.28 |
| 2016-06-30 |
$1.36B |
$1.09B |
1.25 |
| 2016-03-31 |
$1.33B |
$1.10B |
1.21 |
| 2015-12-31 |
$1.31B |
$1.12B |
1.17 |
| 2015-09-30 |
$1.55B |
$1.21B |
1.29 |
| 2015-06-30 |
$1.56B |
$1.20B |
1.30 |
| 2015-03-31 |
$1.57B |
$1.26B |
1.25 |
| 2014-12-31 |
$1.63B |
$1.28B |
1.28 |
| 2014-09-30 |
$1.70B |
$1.37B |
1.24 |
| 2014-06-30 |
$1.84B |
$1.42B |
1.30 |
| 2014-03-31 |
$1.87B |
$1.31B |
1.42 |
| 2013-12-31 |
$1.69B |
$1.38B |
1.22 |
| 2013-09-30 |
$1.91B |
$1.32B |
1.45 |
| 2013-06-30 |
$1.82B |
$1.25B |
1.46 |
| 2013-03-31 |
$1.48B |
$1.27B |
1.17 |
| 2012-12-31 |
$1.64B |
$1.18B |
1.39 |
| 2012-09-30 |
$1.71B |
$1.22B |
1.40 |
| 2012-06-30 |
$1.77B |
$1.24B |
1.43 |
| 2012-03-31 |
$1.78B |
$1.20B |
1.49 |
| 2011-12-31 |
$0.30B |
$0.24B |
1.23 |
| 2011-09-30 |
$0.27B |
$0.21B |
1.25 |
| 2011-06-30 |
$0.26B |
$0.21B |
1.29 |
| 2011-03-31 |
$0.26B |
$0.21B |
1.24 |
| 2010-12-31 |
$0.26B |
$0.19B |
1.37 |
| 2010-09-30 |
$0.23B |
$0.17B |
1.36 |
| 2010-06-30 |
$0.22B |
$0.14B |
1.56 |
| 2010-03-31 |
$0.22B |
$0.15B |
1.49 |
| 2009-12-31 |
$0.23B |
$0.15B |
1.50 |
| 2009-09-30 |
$0.23B |
$0.16B |
1.49 |
| 2009-06-30 |
$0.21B |
$0.14B |
1.49 |
| 2009-03-31 |
$0.20B |
$0.14B |
1.45 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MEDICAL INFO SYS |
$2.428B |
$1.707B |
|
Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
| Veeva Systems Inc. (VEEV) |
US |
$36.657B |
54.02 |
| Hims & Hers Health, Inc. (HIMS) |
US |
$10.767B |
273.78 |
| Tempus AI, Inc. (TEM) |
US |
$10.720B |
0.00 |
| Inspire Medical Systems, Inc. (INSP) |
US |
$5.261B |
102.50 |
| iRhythm Technologies (IRTC) |
US |
$3.752B |
0.00 |
| Privia Health Group, Inc. (PRVA) |
US |
$2.942B |
245.20 |
| Clover Health Investments, Corp. (CLOV) |
US |
$2.205B |
0.00 |
| Azenta, Inc. (AZTA) |
US |
$2.045B |
95.21 |
| Omnicell, Inc. (OMCL) |
US |
$1.840B |
40.12 |
| Schrodinger, Inc. (SDGR) |
US |
$1.650B |
0.00 |
| Phreesia, Inc. (PHR) |
US |
$1.640B |
0.00 |
| 10x Genomics (TXG) |
US |
$1.333B |
0.00 |
| Butterfly Network, Inc. (BFLY) |
US |
$0.916B |
0.00 |
| Talkspace, Inc. (TALK) |
US |
$0.508B |
300.50 |
| Fulgent Genetics, Inc. (FLGT) |
US |
$0.503B |
0.00 |
| Standard BioTools Inc. (LAB) |
US |
$0.484B |
0.00 |
| TruBridge, Inc. (TBRG) |
US |
$0.422B |
122.87 |
| Pulmonx Corporation (LUNG) |
US |
$0.354B |
0.00 |
| Nyxoah SA (NYXH) |
BE |
$0.352B |
0.00 |
| Health Catalyst, Inc. (HCAT) |
US |
$0.318B |
0.00 |
| SOPHiA GENETICS SA (SOPH) |
CH |
$0.266B |
0.00 |
| American Well Corporation (AMWL) |
US |
$0.183B |
0.00 |
| EUDA Health Holdings Limited (EUDA) |
SG |
$0.098B |
0.00 |
| MDxHealth SA (MDXH) |
BE |
$0.088B |
0.00 |
| P3 Health Partners Inc. (PIII) |
US |
$0.075B |
0.00 |
| 111, Inc. Sponsored ADR (YI) |
CN |
$0.072B |
0.00 |
| CareCloud, Inc. (CCLD) |
US |
$0.058B |
0.00 |
| HeartBeam, Inc. (BEAT) |
US |
$0.055B |
0.00 |
| Outset Medical, Inc. (OM) |
US |
$0.047B |
0.00 |
| Zepp Health Corporation Sponsored ADR (ZEPP) |
CN |
$0.045B |
0.00 |
| SHL Telemedicine Ltd. Unsponsored ADR (SHLT) |
IL |
$0.038B |
0.00 |
| Zhongchao Inc. (ZCMD) |
CN |
$0.035B |
0.00 |
| Movano Inc. (MOVE) |
US |
$0.033B |
0.00 |
| Bullfrog AI Holdings Inc. (BFRG) |
US |
$0.025B |
0.00 |
| MSP Recovery, Inc. (MSPR) |
US |
$0.016B |
0.00 |
| Streamline Health Solutions, Inc. (STRM) |
US |
$0.015B |
0.00 |
| Precipio, Inc. (PRPO) |
US |
$0.015B |
0.00 |
| ImmunoPrecise Antibodies Ltd. (IPA) |
CA |
$0.012B |
0.00 |
| Mobile-health Network Solutions (MNDR) |
SG |
$0.012B |
0.00 |
| Strata Skin Sciences, Inc. (SSKN) |
US |
$0.011B |
0.00 |
| Predictive Oncology Inc. (POAI) |
US |
$0.010B |
0.00 |
| Syra Health Corp. (SYRA) |
US |
$0.005B |
0.00 |
| Tivic Health Systems, Inc. (TIVC) |
US |
$0.004B |
0.00 |
| HeartSciences Inc. (HSCS) |
US |
$0.004B |
0.00 |
| Healthcare Triangle, Inc. (HCTI) |
US |
$0.003B |
0.00 |
| Future Health ESG Corp. (FHLT) |
US |
$0.000B |
0.00 |
